Published October 23, 2017

Researchers followed 180 men between the ages of 18 and 65 years with mild or moderate erectile dysfunction, and with or without complaints of low libido. For three months, they gave half of the men three capsules of Tribestan twice a day. They gave the other men a placebo. The International Index of Erectile Function questionnaire (IIEF) scores improved significantly in the Tribestan group. In fact, the scores in the men taking the Tribestan were almost three times better than the men taking the placebo. The Tribestran group also fared better statistically in their Global Efficacy Question (GEQ) scores and reported greater intercourse satisfaction, orgasmic function, libido, and overall satisfaction.

Read More

Published October 20, 2017

Inflammatory hypothesis confirmed: Landmark randomized clinical trial of high-risk patients finds that a drug targeting inflammation reduced risk of major adverse cardiovascular events.

Read More

Published October 18, 2017

Higher amounts of different bacteria were associated with increased concentrations of certain brain metabolites. Alterations in these metabolites are associated with autism spectrum disorder, indicating that bacteria concentrations could be a key part of the equation.

Read More